tiprankstipranks
Meiragtx Holdings (DE:328)
NASDAQ:328
Germany Market

Meiragtx Holdings (328) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

328 Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Meiragtx
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

328 Stock 12 Month Forecast

Average Price Target

€21.88
▲(176.93% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Meiragtx Holdings in the last 3 months. The average price target is €21.88 with a high forecast of €30.63 and a low forecast of €16.63. The average price target represents a 176.93% change from the last price of €7.90.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"€4","31":"€31","10.75":"€10.75","17.5":"€17.5","24.25":"€24.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30.62856825,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€30.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.87754875,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€21.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.62693705,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€16.63</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,10.75,17.5,24.25,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.7,13.15604371153846,14.612087423076922,16.068131134615385,17.524174846153848,18.980218557692307,20.43626226923077,21.89230598076923,23.348349692307693,24.804393403846156,26.260437115384615,27.71648082692308,29.17252453846154,{"y":30.62856825,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.7,12.482888365384614,13.26577673076923,14.048665096153846,14.83155346153846,15.614441826923077,16.39733019230769,17.180218557692307,17.96310692307692,18.745995288461536,19.52888365384615,20.311772019230766,21.094660384615384,{"y":21.87754875,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.7,12.078995157692306,12.457990315384615,12.836985473076922,13.21598063076923,13.594975788461538,13.973970946153845,14.352966103846153,14.73196126153846,15.110956419230767,15.489951576923076,15.868946734615383,16.24794189230769,{"y":16.62693705,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.4,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.55,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.85,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.4,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.55,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.25,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.25,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.5,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.05,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.7,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€30.63Average Price Target€21.88Lowest Price Target€16.63
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Cantor Fitzgerald Analyst forecast on DE:328
Cantor Fitzgerald
Cantor Fitzgerald
€17.5
Buy
121.54%
Upside
Reiterated
07/09/26
Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (NASDAQ: MGTX) and Sensus Healthcare (NASDAQ: SRTS)
Piper Sandler Analyst forecast on DE:328
Piper Sandler
Piper Sandler
€26.25
Buy
232.32%
Upside
Reiterated
07/08/26
Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Meiragtx Holdings (NASDAQ: MGTX) and Resmed (NYSE: RMD)
H.C. Wainwright Analyst forecast on DE:328
H.C. Wainwright
H.C. Wainwright
€17.5
Buy
121.54%
Upside
Reiterated
07/08/26
Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (NASDAQ: MGTX) and Vera Therapeutics (NASDAQ: VERA)
RBC Capital Analyst forecast on DE:328
RBC Capital
RBC Capital
€21.88€22.75
Buy
188.01%
Upside
Reiterated
07/08/26
MeiraGTx price target raised to $26 from $25 at RBC CapitalMeiraGTx price target raised to $26 from $25 at RBC Capital
Bank of America Securities Analyst forecast on DE:328
Bank of America Securities
Bank of America Securities
€16.63
Buy
110.47%
Upside
Reiterated
07/07/26
Alec Stranahan Reaffirms Buy on MeiraGTx as Oberland Financing Strengthens Balance Sheet and Upcoming AQUAx2 and Bota-Vec Catalysts Support Upside
Raymond James Analyst forecast on DE:328
Unknown Analyst
Raymond James
Not Ranked
Raymond James
Buy
Reiterated
06/24/26
Meiragtx Holdings (MGTX) Gets a Buy from Raymond James
Chardan Capital Analyst forecast on DE:328
Chardan Capital
Chardan Capital
€30.63
Buy
287.70%
Upside
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN), Cardiff Oncology (NASDAQ: CRDF) and Meiragtx Holdings (NASDAQ: MGTX)
Evercore ISI
€17.5€15.75
Buy
99.39%
Upside
Reiterated
04/01/26
MeiraGTx price target lowered to $18 from $20 at Evercore ISIMeiraGTx price target lowered to $18 from $20 at Evercore ISI
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Cantor Fitzgerald Analyst forecast on DE:328
Cantor Fitzgerald
Cantor Fitzgerald
€17.5
Buy
121.54%
Upside
Reiterated
07/09/26
Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (NASDAQ: MGTX) and Sensus Healthcare (NASDAQ: SRTS)
Piper Sandler Analyst forecast on DE:328
Piper Sandler
Piper Sandler
€26.25
Buy
232.32%
Upside
Reiterated
07/08/26
Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Meiragtx Holdings (NASDAQ: MGTX) and Resmed (NYSE: RMD)
H.C. Wainwright Analyst forecast on DE:328
H.C. Wainwright
H.C. Wainwright
€17.5
Buy
121.54%
Upside
Reiterated
07/08/26
Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (NASDAQ: MGTX) and Vera Therapeutics (NASDAQ: VERA)
RBC Capital Analyst forecast on DE:328
RBC Capital
RBC Capital
€21.88€22.75
Buy
188.01%
Upside
Reiterated
07/08/26
MeiraGTx price target raised to $26 from $25 at RBC CapitalMeiraGTx price target raised to $26 from $25 at RBC Capital
Bank of America Securities Analyst forecast on DE:328
Bank of America Securities
Bank of America Securities
€16.63
Buy
110.47%
Upside
Reiterated
07/07/26
Alec Stranahan Reaffirms Buy on MeiraGTx as Oberland Financing Strengthens Balance Sheet and Upcoming AQUAx2 and Bota-Vec Catalysts Support Upside
Raymond James Analyst forecast on DE:328
Unknown Analyst
Raymond James
Not Ranked
Raymond James
Buy
Reiterated
06/24/26
Meiragtx Holdings (MGTX) Gets a Buy from Raymond James
Chardan Capital Analyst forecast on DE:328
Chardan Capital
Chardan Capital
€30.63
Buy
287.70%
Upside
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN), Cardiff Oncology (NASDAQ: CRDF) and Meiragtx Holdings (NASDAQ: MGTX)
Evercore ISI
€17.5€15.75
Buy
99.39%
Upside
Reiterated
04/01/26
MeiraGTx price target lowered to $18 from $20 at Evercore ISIMeiraGTx price target lowered to $18 from $20 at Evercore ISI
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Meiragtx Holdings

3 Months
Christopher RaymondRaymond James
Success Rate
6/11 ratings generated profit
55%
Average Return
+3.02%
Copying Christopher Raymond's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +3.02% per trade.
1 Year
Lisa WalterRBC Capital
Success Rate
6/8 ratings generated profit
75%
Average Return
+49.84%
Copying Lisa Walter's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +49.84% per trade.
2 Years
Lisa WalterRBC Capital
Success Rate
7/8 ratings generated profit
88%
Average Return
+70.79%
Copying Lisa Walter's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +70.79% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

328 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
4
7
10
7
5
Buy
0
0
0
1
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
7
10
8
9
In the current month, 328 has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 328 average Analyst price target in the past 3 months is 21.88.
Each month's total comprises the sum of three months' worth of ratings.

328 Financial Forecast

328 Earnings Forecast

Next quarter’s earnings estimate for 328 is -€0.29 with a range of -€0.53 to €0.39. The previous quarter’s EPS was -€0.50. 328 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 328 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 328 is -€0.29 with a range of -€0.53 to €0.39. The previous quarter’s EPS was -€0.50. 328 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 328 has Performed in-line its overall industry.

328 Sales Forecast

Next quarter’s sales forecast for 328 is €613.06K with a range of €0.00 to €1.40M. The previous quarter’s sales results were €256.61K. 328 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 328 has Performed in-line its overall industry.
Next quarter’s sales forecast for 328 is €613.06K with a range of €0.00 to €1.40M. The previous quarter’s sales results were €256.61K. 328 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 328 has Performed in-line its overall industry.

328 Stock Forecast FAQ

What is DE:328’s average 12-month price target, according to analysts?
Based on analyst ratings, Meiragtx Holdings’s 12-month average price target is 21.88.
    What is DE:328’s upside potential, based on the analysts’ average price target?
    Meiragtx Holdings has 176.93% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Meiragtx Holdings a Buy, Sell or Hold?
          Meiragtx Holdings has a consensus rating of Strong Buy, which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Meiragtx Holdings’s share price target?
            The average share price target for Meiragtx Holdings is 21.88. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €30.63 ,and the lowest forecast is €16.63. The average share price target represents 176.93% Increase from the current price of €7.9.
              What do analysts say about Meiragtx Holdings?
              Meiragtx Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of Meiragtx Holdings?
                To buy shares of DE:328, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.